Delivery Order SPE2DR25D2014-SPE2DR26FA2F3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,301.66 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) on January 10, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price, non-set-aside delivery order was placed to the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,755.70 to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100 count) on January 7, 2026, with completion scheduled for January 8, 2026. This competitively awarded, firm fixed-price delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, operates as a comprehensive global...
- The Defense Logistics Agency awarded a $2,315.52 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100 count) on November 12, 2025, with completion targeted for November 13, 2025. This firm fixed-price contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract is non-set-aside and was competitively awarded, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $1,045.05 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100 count) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of OxyContin ER 20 mg, valued at $1,472.29, with performance in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside provisions and carries a firm fixed-price structure with a completion date of January 8, 2026. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,438.70 for OxyContin ER 20 mg tablets (100-count) on December 10, 2025, with a completion date of December 11, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $10,091.11 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on November 20, 2025, with an ultimate completion date of November 21, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of OxyContin ER 80 mg tablets (100-count units) valued at $4,901.31. This is a firm fixed-price delivery order with an ultimate completion date of December 12, 2025, with no set-aside designation. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,175.30 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100-count units). The contract is unclassified as a set-aside and carries a firm fixed-price structure with an ultimate completion date of January 12, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this order from its corporate office location. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,423.36 for OxyContin ER 10 mg tablets (100-count units) with a completion date of December 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA2F3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,037.29 to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of OxyContin ER 10 mg tablets in quantities of 100. This is a firm fixed-price, non-set-aside contract with a completion date of January 13, 2026, and performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems, particularly those supporting military and veteran populations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs worldwide. The competitive award reflects the contractor's established capability to meet federal procurement requirements for essential pharmaceutical commodities across multiple therapeutic domains, including pain management medications such as those covered under this specific order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/11/26 |